Subsequent verification revealed that METTL16 knockdown resulted in reduced Soga1 mRNA levels, whereas METTL16 over‐expression increased Soga1 mRNA levels in CRC cells (Figure 4C,D). Here, METTL16 is linked to colorectal carcinoma.